Canary Speech logo

Canary Speech Funding & Investors

Provo, UT

Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocal biomarker technology models acoustic and linguistic features and returns analysis. Canary detects stress, mood, and energy levels before traditional clinical screening and visible symptoms, allowing clinicians, payers, and patients to address conditions more proactively. Canary's technology reduces readmissions, prevents hospitalizations, and provides a head start on wellness for patients and providers. Its current research simulates respiratory conditions, dementia and Alzheimer's disease, and clinical deterioration, with broad practical implications for simulating other disease states.

canaryspeech.com

Total Amount Raised: $18,266,288

Canary Speech Funding Rounds

  • Series A

    $13,000,000

    Series A Investors

    Cortes capital
    Hackensack Meridian Health
    SMK
    Sorenson Communications
  • Series Unknown

    $1,891,290

  • Series Unknown

    $2,799,999

  • Series Unknown

    $575,000

Funding info provided by Diffbot.